Lab-scale production unit design for nanosuspensions of sparingly soluble cytotoxic drugs

被引：56

作者：

Böhm, BHL ^{[1
]}

Müller, RH ^{[1
]}

机构：

[1] Free Univ Berlin, Inst Pharm Pharmaceut Technol Biotechnol & Biopha, D-12169 Berlin, Germany

来源：

PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY | 1999年 / 2卷 / 08期

关键词：

D O I：

10.1016/S1461-5347(99)00177-7

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Cytotoxic agent processing assumes certain prerequisites in order to guarantee a high level of security for both personnel and the material used. A lab-scale unit designed for the production and analysis of nanosuspensions of cytotoxic agents has been in use for more than three years. This design encompasses equipment, exhaust systems, materials used and measures for staff security, and this lab suite may also be used in applications that involve production in aseptic conditions.

引用

页码：336 / 339

页数：4

共 10 条

[1]

BOHM BHL, 1997, P INT S CONTR REL BI, V24, P927

[2]

BOHM BHL, 1998, P 2 WORLD M APGI APV, P621

[3]

GRANT DJW, 1995, PHYS CHARACTERIZATIO, P322

[4] PARTICLE-SIZE REDUCTION FOR IMPROVEMENT OF ORAL BIOAVAILABILITY OF HYDROPHOBIC DRUGS .1. ABSOLUTE ORAL BIOAVAILABILITY OF NANOCRYSTALLINE DANAZOL IN BEAGLE DOGS [J].

LIVERSIDGE, GG ;

CUNDY, KC .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 125 (01) :91-97

[5] DRUG PARTICLE-SIZE REDUCTION FOR DECREASING GASTRIC IRRITANCY AND ENHANCING ABSORPTION OF NAPROXEN IN RATS [J].

LIVERSIDGE, GG ;

CONZENTINO, P .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 125 (02) :309-313

[6] HISTAMINE-RELEASE AND HYPOTENSIVE REACTIONS IN DOGS BY SOLUBILIZING AGENTS AND FATTY-ACIDS - ANALYSIS OF VARIOUS COMPONENTS IN CREMOPHOR EL AND DEVELOPMENT OF A COMPOUND WITH REDUCED TOXICITY [J].

LORENZ, W ;

SCHMAL, A ;

SCHULT, H ;

LANG, S ;

OHMANN, C ;

WEBER, D ;

KAPP, B ;

LUBEN, L ;

DOENICKE, A .

AGENTS AND ACTIONS, 1982, 12 (1-2) :64-80

[7] THE EFFECT OF PARTICLE-SIZE AND SHAPE ON THE SURFACE SPECIFIC DISSOLUTION RATE OF MICROSIZED PRACTICALLY INSOLUBLE DRUGS [J].

MOSHARRAF, M ;

NYSTROM, C .

INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 122 (1-2) :35-47

[8]

Müller RH, 1999, PHARM IND, V61, P175

[9]

Muller RH., 1998, Emulsions and nanosuspensions for the formulation of poorly soluble drugs, P149

[10] PACLITAXEL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL IN THE TREATMENT OF CANCER [J].

SPENCER, CM ;

FAULDS, D .

DRUGS, 1994, 48 (05) :794-847

← 1 →